Amendment3.pdf

OFFICE OF ACQUISITIONS

NATIONAL CANCER INSTITUTE

REQUEST FOR PROPOSAL NUMBER: N02CN35003-43

Amendment No.: 3

Date of Issuance: 09/25/2013

The above numbered Request For Proposal (RFP) is amended as set forth below. The hour and date specified for receipt of Offerors remains unchanged.

Offerors MUST acknowledge receipt of the amendment prior to the hour and the date specified in the solicitation or as amended, by separate letter, telegram, or Electronic Mail which includes a reference to the RFP and Amendment number(s). For your convenience, the Proposal Intent Response Form is provided in SECTION J - List of Attachments of this RFP, for this purpose.

FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERORS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER.

This Amendment revises the RFP as stated below:

The following questions and answers are provided to help with preparation of proposals.

1. Will the successful offeror be able to take on the existing instance of OC RDC as-is from incumbent?

The existing instance of OC-RDC will not be transferred to the successful offeror. However, the successful offeror will be provided with source code for the project including data definitions, view definitions, and value lists that can be used to reconstruct the database.

2. What version of OC RDC are the current studies in?

The version of OC-RDC in current use is OC-RDC HTLM Onsite 4.6.5

3. Can NCI provide specifics on the licensing agreement with Oracle (support included?)

The specifics of a licensing agreement appropriate for this solicitation should be discussed with Oracle.

4. Is the Oracle support maintained/contracted by NCI?

The Oracle support is not maintained or contracted by the NCI, and will be the responsibility of the successful offeror.

5. Has the incumbent made any changes to Oracle Clinical instance (as originally provided by Oracle)?

The incumbent has made changes to Oracle Clinical to support the current DCP project.

6. What Oracle database version (RDBMS) is currently being used?

The Oracle database version in current use is V11.2.0.3.

7. What is the approximate size of the Database for 2003 consortia studies?

The approximate size of the current OC-RDC database is 20GB.

8. Can the offeror propose migrating existing studies to a newer version of OC RDC or do they need to remain in their current versions?

The offeror may propose migrating existing studies to a newer version of OC-RDC.

9. Can NCI release the list of additional systems that need to be supported under this contract?

The additional systems to be hosted and/or supported include the following:

Clinical Data Transfer website (CDT) - provides a secure method of access for OC-RDC and other users to study-specific datasets, reports, and user documentation, and will be hosted and supported by the successful offeror.

secure FTP site (SFTP) – provides a method for the secure transfer of designated study data between the successful offeror and the Consortia Lead Organizations, and will be hosted and supported by the successful offeror.

DCP Helpdesk – provides a resource for Consortia and DCP staff to address questions and issues regarding OC-RDC, auditing and general administrative issues, and will be hosted and supported by the successful offeror.

DCP Collaboration Repository –provides a secure point of access from DCP enterprise information may be shared among multiple users, and is supported by the successful offeror.

10. Are there any licenses outside of OC-RDC that the successful offeror will need to maintain/support in relationship to this contract?

The successful offeror will be required to maintain a current license for SAS®.

11. Please confirm that hosting of existing systems utilized by NCI DCP (with an exception of OC-RDC) is not required for this contract.

Please see response to question #9.